{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T20:34:17Z","timestamp":1770928457949,"version":"3.50.1"},"reference-count":54,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1185\/03007995.2012.762903","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T08:28:08Z","timestamp":1357201688000},"page":"227-239","source":"Crossref","is-referenced-by-count":10,"title":["The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia"],"prefix":"10.1185","volume":"29","author":[{"given":"P.","family":"Chue","sequence":"first","affiliation":[{"name":"University of Alberta","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Malla","sequence":"additional","affiliation":[{"name":"McGill University","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.-H.","family":"Bouchard","sequence":"additional","affiliation":[{"name":"University of Laval","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lessard","sequence":"additional","affiliation":[{"name":"University of Ottawa","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ganesan","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Stip","sequence":"additional","affiliation":[{"name":"University of Montreal","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Johnson","sequence":"additional","affiliation":[{"name":"University of Toronto","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Chen","sequence":"additional","affiliation":[{"name":"University of Hong Kong","place":["Hong Kong"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.M.","family":"Ahn","sequence":"additional","affiliation":[{"name":"Seoul National University","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.S.","family":"Kim","sequence":"additional","affiliation":[{"name":"Seoul National University","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Metro South Mental Health and Griffith University","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schweikert","sequence":"additional","affiliation":[{"name":"AstraZeneca","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gendron","sequence":"additional","affiliation":[{"name":"University of Montreal","place":["Canada"]},{"name":"AstraZeneca","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Eriksson","sequence":"additional","affiliation":[{"name":"AstraZenecaSweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the SPECTRUM XR Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,1,22]]},"reference":[{"key":"e_1_3_3_2_1","first-page":"7","article-title":"Clinical practice guidelines. Treatment of schizophrenia","volume":"50","author":"Canadian Psychiatric Association","year":"2005","unstructured":"Canadian Psychiatric Association. Clinical practice guidelines. Treatment of schizophrenia. Can J Psychiatry 2005;50:7-57S","journal-title":"Can J Psychiatry"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/j.1440-1614.2005.01516.x"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp116"},{"key":"e_1_3_3_5_1","unstructured":"National Institute for Health and Clinical Excellence. Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care (update) National Clinical Practice Guideline Number 82. National Collaborating Centre for Mental Health Commissioned by the National Institute for Health and Clinical Excellence 2009"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651500510029192"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519010-00003"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051688"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0114"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60486-9"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.2174\/157488406775268255"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.s3346"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1091"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.64719\/pb.4322","article-title":"The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study","volume":"41","author":"Lindenmayer JP","year":"2008","unstructured":"Lindenmayer JP, Brown D, Liu S, et al. The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study. Psychopharmacol Bull 2008;41:11-35","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0603"},{"key":"e_1_3_3_16_1","first-page":"34","article-title":"Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients","volume":"4","author":"Peuskens J","year":"2007","unstructured":"Peuskens J, Trivedi J, Malyarov S, et al. Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients. Psychiatry (Edgmont) 2007;4:34-50","journal-title":"Psychiatry (Edgmont)"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.64719\/pb.4302","article-title":"A failed 6-week, randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned","volume":"43","author":"Cutler AJ","year":"2010","unstructured":"Cutler AJ, Tran-Johnson T, Kalali A, et al. A failed 6-week, randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned. Psychopharmacol Bull 2010;43:37-69","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3282f2d42c"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X253384"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990902738810"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328337789b"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S14369"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","unstructured":"Guy W. ECDEU assessment manual for psychopharmacology. US Institute of Health 1976","DOI":"10.1037\/e591322011-001"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.09.006"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300873"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2005.00688.x"},{"key":"e_1_3_3_27_1","unstructured":"AstraZeneca Canada Inc. Seroquel XR Product Monograph. Date of revision: April 2 2012"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1586\/ern.12.138"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000337739"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1159\/000339092"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2012.08.030"},{"issue":"11","key":"e_1_3_3_32_1","first-page":"1","article-title":"From clinical research to clinical practice: a 4-year review of ziprasidone","volume":"10","author":"Nemeroff CB","year":"2005","unstructured":"Nemeroff CB, Lieberman JA, Weiden PJ, et al. From clinical research to clinical practice: a 4-year review of ziprasidone. CNS Spectr 2005;10(11 S17):1-20","journal-title":"CNS Spectr"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0924-2708.2004.00098.x"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32832c2624"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181842586"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.04.008"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711000514"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0111"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.09.026"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0712"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)89080-3"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015030-00001"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291799001476"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200311000-00007"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S3153"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000237947.80764.d9"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2010.0020"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07246"},{"key":"e_1_3_3_49_1","volume-title":"Atypical antipsychotics: A bench to bedside perspective for clinicians","author":"Chue P","year":"2004","unstructured":"Chue P. Metabolic regulation and atypical antipsychotic drugs. In: Atypical antipsychotics: A bench to bedside perspective for clinicians (Eds. J Csernansky, J Lauriello). New York: Marcel Dekker Inc., 2004"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2009.12.016"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2009.01.005"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2009.05.018"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32834a5bf6"},{"key":"e_1_3_3_54_1","first-page":"3","article-title":"Evaluating antipsychotic medications: predictors of clinical effectiveness. Report of an expert review panel on efficacy and effectiveness","volume":"48","author":"Lalonde P","year":"2003","unstructured":"Lalonde P. Evaluating antipsychotic medications: predictors of clinical effectiveness. Report of an expert review panel on efficacy and effectiveness. Can J Psychiatry 2003;48:3-12S","journal-title":"Can J Psychiatry"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370204700607"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007995.2012.762903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T19:48:31Z","timestamp":1770925711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007995.2012.762903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,22]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1185\/03007995.2012.762903"],"URL":"https:\/\/doi.org\/10.1185\/03007995.2012.762903","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,22]]}}}